About IDEA Biomedical
IDEA Biomedical is a company based in Rehovot (Israel) founded in 2007. IDEA Biomedical offers products and services including WiScan® Hermes and WiSoft® Athena. IDEA Biomedical operates in a competitive market with competitors including Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
- Headquarter Rehovot, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Idea Bio-Medical Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$100.49 K (USD), Grant
Sep 01, 2018
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IDEA Biomedical
IDEA Biomedical offers a comprehensive portfolio of products and services, including WiScan® Hermes and WiSoft® Athena.
Automated microscopy for high-content cell and zebrafish analysis.
Software for processing images in cell biology research.
People of IDEA Biomedical
Unlock access to complete
Unlock access to complete
Funding Insights of IDEA Biomedical
Investors in IDEA Biomedical
IDEA Biomedical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for IDEA Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IDEA Biomedical
Investment portfolio details for IDEA Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IDEA Biomedical
Detailed financials for IDEA Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Idea Biomedical Comparisons
Peer comparison for IDEA Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IDEA Biomedical
IDEA Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Phoremost, Rheonix, 64x Bio, reMYND and Molcure, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Phenotypic screening platform developed to identify drug targets and pathways.
|
|
| Locked | Locked | Locked |
Instruments for automated molecular assays are developed using disposable cartridges.
|
|
| Locked | Locked | Locked |
Cell and gene therapies for multiple diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of a drug pipeline programs for neurodegenerative diseases
|
|
| Locked | Locked | Locked |
AI-based platform for drug discovery and antibody detection is provided.
|
|
| Locked | Locked | Locked |
Protein design, synthesis, testing, and validation services are offered.
|
Detailed competitors of IDEA Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Idea Biomedical
Complete news archive for IDEA Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IDEA Biomedical
IDEA Biomedical was founded in 2007 and raised its 1st funding round 8 years after it was founded.
IDEA Biomedical is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.
IDEA Biomedical was founded in 2007 in Rehovot, Israel, and operates in the biomedical sector. Imaging systems for research applications are developed, with a focus on high-content screening processes. The flagship product, WiScan, is utilized for biological cell imaging, emphasizing image quality and acquisition speed. Additional offerings include WiSoft, an analysis software with image processing algorithms, and WiSense, a microplate platform for reagent status control.
IDEA Biomedical offers WiScan® Hermes and WiSoft® Athena.
IDEA Biomedical has 1 investor. Key investors include European Union.